Development and Evaluation of a new technological way of engaging patients and enhancing understanding of drug tolerability in early clinical development: PROACT.
Hughes, A Landers, D Arkenau, H Shah, S Stephens, R Mahal, A Simmons, M Lemech, C Royle, Jennifer
Hughes, A
Landers, D
Arkenau, H
Shah, S
Stephens, R
Mahal, A
Simmons, M
Lemech, C
Royle, Jennifer
Citations
Altmetric:
Abstract
During early clinical testing of a new medication, it is critical to understand and characterise patient tolerability. However, in early clinical studies, it is difficult for patients to contribute directly to the sponsors' understanding of a new compound. Patient reported opinions about clinical tolerability (PROACT) provides a new, simple and innovative way in which patients can collaborate using an application downloaded to a mobile computer or smartphone.
Description
Date
2016-05-11
Publisher
Collections
Keywords
Type
Article
Citation
Development and Evaluation of a new technological way of engaging patients and enhancing understanding of drug tolerability in early clinical development: PROACT. 2016: Adv Ther